Trexquant Investment’s KALA BIO KALA Stock Holding History

Trexquant Investment’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6	Closed	-$140K	–	1167
2018 Q3	$140K	Buy	+6	New	+$183K	0.01%	872

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Trexquant Investment's KALA Position: Q4 2018 in Review

Trexquant Investment sold out of KALA BIO (KALA) in Q4 2018, closing a stake of 6 shares — an estimated $140K sold.

Trexquant Investment first reported a position in KALA in Q3 2018 and held it in 1 quarter. The position peaked at $140K in Q3 2018. 64 funds tracked by Wall St. Rank hold KALA as of Q4 2018.

Trexquant Investment reported no remaining KALA BIO position as of Q4 2018 after selling out during the quarter.
Trexquant Investment sold 6 KALA BIO shares in Q4 2018, an estimated $140K.
Trexquant Investment first reported a position in KALA BIO in Q3 2018 and held it in 1 quarter.
Trexquant Investment's KALA BIO position peaked at $140K in Q3 2018.
64 funds tracked by Wall St. Rank held KALA BIO as of Q4 2018.

Based on Trexquant Investment's 13F filing for Q4 2018, filed 13 Feb 2019.